INS and type 2 diabetes mellitus: This real-world, retrospective study evaluated fall/fracture-related healthcare resource utilization (HCRU) and costs in people with type 2 diabetes aged 50 years and older treated with longer-acting Gla-300 vs long-acting basal insulins (Gla-100/IDet 100 U/mL) or NPH insulin and also the association between fall/fracture events and hypoglycemia.